Mutations in the isocitrate dehydrogenase (IDH1 or IDH2) genes are common in enchondromas and chondrosarcomas, and lead to elevated levels of the oncometabolite D-2-hydroxyglutarate causing widespread changes in the epigenetic landscape of these tumors. With the use of a DNA methylation array, we explored whether the methylome is altered upon progression from IDH mutant enchondroma towards high-grade chondrosarcoma. High-grade tumors show an overall increase in the number of highly methylated genes, indicating that remode
Chondrosarcomas are the second most common primary bone malignancy. Chondrosarcomas are characterize...
Chondrosarcomas are the second most common primary bone malignancy. Chondrosarcomas are characterize...
Chondrosarcomas are the second most common primary bone malignancy. Chondrosarcomas are characterize...
Mutations in the isocitrate dehydrogenase (IDH1 or IDH2) genes are common in enchondromas and chondr...
Mutations in the isocitrate dehydrogenase (IDH1 or IDH2) genes are common in enchondromas and chondr...
Simple SummaryCartilage tumors frequently harbor mutations in the isocitrate dehydrogenase (IDH1 or ...
Simple SummaryCartilage tumors frequently harbor mutations in the isocitrate dehydrogenase (IDH1 or ...
Chondrosarcomas constitute a heterogeneous group of malignant bone tumors that produce hyaline carti...
More than 50% of patients with chondrosarcomas exhibit gain-of-function mutations in either isocitra...
Mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 are found in a subset of benign and malignan...
Mutations in genes encoding enzymes of the tricarboxylic acid cycle often contribute to cancer devel...
<div><p>Chondrosarcomas are malignant bone tumors that produce cartilaginous matrix. Mutations in is...
<div><p>Somatic mutations in the <i>isocitrate dehydrogenase</i> (<i>IDH)1/2</i> genes endow encodin...
Chondrosarcomas are malignant bone tumors that produce cartilaginousmatrix. Mutations in isocitrate ...
Genes encoding for isocitrate dehydrogenases 1 and 2, IDH1 and IDH2, are frequently mutated in multi...
Chondrosarcomas are the second most common primary bone malignancy. Chondrosarcomas are characterize...
Chondrosarcomas are the second most common primary bone malignancy. Chondrosarcomas are characterize...
Chondrosarcomas are the second most common primary bone malignancy. Chondrosarcomas are characterize...
Mutations in the isocitrate dehydrogenase (IDH1 or IDH2) genes are common in enchondromas and chondr...
Mutations in the isocitrate dehydrogenase (IDH1 or IDH2) genes are common in enchondromas and chondr...
Simple SummaryCartilage tumors frequently harbor mutations in the isocitrate dehydrogenase (IDH1 or ...
Simple SummaryCartilage tumors frequently harbor mutations in the isocitrate dehydrogenase (IDH1 or ...
Chondrosarcomas constitute a heterogeneous group of malignant bone tumors that produce hyaline carti...
More than 50% of patients with chondrosarcomas exhibit gain-of-function mutations in either isocitra...
Mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 are found in a subset of benign and malignan...
Mutations in genes encoding enzymes of the tricarboxylic acid cycle often contribute to cancer devel...
<div><p>Chondrosarcomas are malignant bone tumors that produce cartilaginous matrix. Mutations in is...
<div><p>Somatic mutations in the <i>isocitrate dehydrogenase</i> (<i>IDH)1/2</i> genes endow encodin...
Chondrosarcomas are malignant bone tumors that produce cartilaginousmatrix. Mutations in isocitrate ...
Genes encoding for isocitrate dehydrogenases 1 and 2, IDH1 and IDH2, are frequently mutated in multi...
Chondrosarcomas are the second most common primary bone malignancy. Chondrosarcomas are characterize...
Chondrosarcomas are the second most common primary bone malignancy. Chondrosarcomas are characterize...
Chondrosarcomas are the second most common primary bone malignancy. Chondrosarcomas are characterize...